Roblin, X., Nancey, S., Barrau, M., Papamichail, K., Cheifetz, A., & Paul, S. (2026). Higher colonic tissue drug concentrations of subcutaneous compared to intravenous infliximab administration in patients with Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 20, i1867.
Chicago Style (17th ed.) CitationRoblin, X., S. Nancey, M. Barrau, K. Papamichail, A. Cheifetz, and S. Paul. "Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Infliximab Administration in Patients with Inflammatory Bowel Disease." Journal of Crohn's & Colitis 20 (2026): i1867.
MLA (9th ed.) CitationRoblin, X., et al. "Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Infliximab Administration in Patients with Inflammatory Bowel Disease." Journal of Crohn's & Colitis, vol. 20, 2026, p. i1867.